0.1937

3.73% -0.0075

After Hours: .20 0.0063 +3.25%

Tnf Pharmaceuticals Inc (TNFA)

Overview News Price History Discussions Forecast

Tnf Pharmaceuticals Inc stock is traded at $0.1937, with a volume of 1.99M. It is down -3.73% in the last 24 hours and down -47.78% over the past month. TNF Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. The company is developing and commercializing two therapeutic platforms, Isomyosamine and Supera-CBD. Isomyosamine is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. It is being developed to treat age-related illnesses such as frailty and sarcopenia. Supera-CBD is a synthetic derivative of CBD being developed to treat various conditions, including epilepsy, pain, and anxiety/depression, through its effects on the CB2 receptor, opioid receptors, and monoamine oxidase enzyme type B. The company has one reportable segment focused on Isomyosamine.

Previous Close:

$0.2012

Open:

$0.1987

24h Volume:

1.99M

Relative Volume:

1.56

Market Cap:

$2.26M

Revenue:

Net Income/Loss:

$-23.66M

P/E Ratio:

-0.014

EPS:

-13.84

Net Cash Flow:

$-10.14M

1W Performance:

-13.06%

1M Performance:

-47.78%

6M Performance:

-85.56%

1Y Performance:

+0.00%

1-Day Range:

$0.1864

$0.207

1-Week Range:

$0.1815

$0.2386

52-Week Range:

$0.1615

$2.16

Tnf Pharmaceuticals Inc Stock (TNFA) Company Profile

Name

Tnf Pharmaceuticals Inc

Sector

Healthcare (1150)

Industry

Biotechnology (676)

Phone

856-848-8698

Address

1185 AVENUE OF THE AMERICAS, NEW YORK

Employee

Twitter

Next Earnings Date

Latest SEC Filings

TNFA's Discussions on Twitter

Compare TNFA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TNFA Tnf Pharmaceuticals Inc	0.1937	2.26M	0	-23.66M	-10.14M	-13.84
VRTX Vertex Pharmaceuticals Inc	500.19	127.64B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	603.58	65.95B	14.09B	4.50B	2.96B	39.28
ARGX Argen X Se Adr	656.65	37.92B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	273.55	32.98B	2.35B	-269.70M	-75.39M	-2.09
ONC Beigene Ltd Adr	254.16	26.92B	3.81B	-644.79M	-669.77M	-6.24

Tnf Pharmaceuticals Inc Stock (TNFA) Latest News

Apr 30, 2025

A new trading data show TNF Pharmaceuticals Inc (TNFA) is showing positive returns. - Sete News

Apr 30, 2025

Apr 28, 2025

TNF Pharmaceuticals Inc Inc. (TNFA) Price Performance: A Guide to Financial Ratios - investchronicle.com

Apr 28, 2025

Is TNF Pharmaceuticals Inc (TNFA) worth investing in despite its overvalued state? - uspostnews.com

Apr 28, 2025

Apr 26, 2025

Gaining Ground: TNF Pharmaceuticals Inc (TNFA) Closes Lower at 0.25, Down -9.00 - DWinneX

Apr 26, 2025

Comparing TNF Pharmaceuticals (NASDAQ:TNFA) & Oruka Therapeutics (NASDAQ:ORKA) - Defense World

Apr 26, 2025

Apr 25, 2025

TNF Pharmaceuticals Inc (NASDAQ:TNFA) Is Looking Good Over The Long Term, Dropped Nearly -46.01% Over A Month. – Marketing Sentinel - Marketing Sentinel

Apr 25, 2025

Apr 24, 2025

Sarcopenia Clinical Trial Pipeline Appears Robust With 18+ - GlobeNewswire

Apr 24, 2025

Sarcopenia Clinical Trial Pipeline Appears Robust With 18+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - GlobeNewswire Inc.

Apr 24, 2025

Apr 23, 2025